SEC Form 4 · accession 0002075052-26-000004
Scribe Therapeutics, Inc. · SCTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua Bleharski
Director
Period of report
Jul 23, 2026
Accepted (ET)
Jul 27, 2026 · 9:22 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001853921
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $15.00 | Jul 23, 2026 | A | 14,725 | A | — | Jul 22, 2036 | Common Stock | 14,725 | 14,725 | D |
Explanation of responses
- F1The options will vest as to 1/3 of the total shares on each of July 23, 2027, July 23, 2028 and July 23, 2029, subject to the Reporting Person's provision of service to the Issuer on each vesting date.